At Becker's ASC Meeting in Chicago on Oct. 23, Kenny Hancock, president and chief development officer at Brentwood, Tenn.-based Meridian Surgical Partners explained the key market drivers that are increasing the migration of spine and higher acuity cases to the…
ASC Transactions & Valuation Issues
At the Becker's ASC 21st Annual Meeting in Chicago on Oct. 23, Aaron Murski, senior manager of VMG Health, and Colin Park, manager of VMG Health, discussed emerging trends in valuations and acquisitions in the ambulatory surgical center industry.
At the Becker's ASC 21st Annual Meeting in Chicago on Oct. 23, five experts from the ambulatory surgery center industry discussed the outlook for investment, mergers and acquisitions in the ASC sector.
Southeastern Health Park has held an open house at its newly opened surgery center in Lumberton, N.C., according to a report from the Robesonian.
The John Lock Foundation, a political organization in North Carolina, has hosted a lecture on that state's certificate of need law on healthcare organizations, according to a report from Forbes.
Advertisement
In late 2012, Becker's Hospital Review published a column I wrote titled "10 Things to Know About Turning a Surgery Center Into a Hospital Outpatient Department." This was a hot topic at the time, and the article received significant attention…
Nontraded real estate investment trusts are down 18 percent from this time last year, according to a report from The Wall Street Journal.
At the 21st Annual Becker's ASC Conference in Chicago on Oct. 23, Vivek Taparia, MBA, director of operations of Regent Surgical Health, discussed the factors that influence the conversion of an ambulatory surgical center to a hospital outpatient department, and…
At the 21st Annual Becker's ASC Conference in Chicago on Oct. 23, Robin Fowler, MD, chairman and medical director of Atlanta, Ga.-based Interventional Management Services, and Stephen Rosenbaum, CEO of Interventional Management Services, presented four strategies for successful ASC expansion…
Monroe Capital was the sole lead arranger and administrative agent for a $20 million senior credit facility funding to sponsor Cytovance Biologics' growth.